These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms. Carroll N J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658 [TBL] [Abstract][Full Text] [Related]
4. [Effectiveness and tolerance of pulsed estrogen therapy in the treatment of menopausal symptoms. Results of a Polish multicenter study]. Szamatowicz M Ginekol Pol; 2005 Mar; 76(3):245-51. PubMed ID: 16018146 [TBL] [Abstract][Full Text] [Related]
5. [Indications and controindications of hormone replacement therapy in menopause]. Fichera M; Rinaldi N; Tarascio M; Taschetta S; Caldaci LM; Catavorello A; La Rosa B; Panella MM Minerva Ginecol; 2013 Jun; 65(3):331-44. PubMed ID: 23689177 [TBL] [Abstract][Full Text] [Related]
6. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety. Crandall C J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124 [TBL] [Abstract][Full Text] [Related]
7. Hormone therapy for the management of menopause symptoms. Collins Fantasia H; Sutherland MA J Obstet Gynecol Neonatal Nurs; 2014; 43(2):226-35; quiz E18-9. PubMed ID: 24502325 [TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies. Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179 [TBL] [Abstract][Full Text] [Related]
9. Relief of hot flushes with new plant-derived 10-component synthetic conjugated estrogens. Utian WH; Lederman SA; Williams BM; Vega RY; Koltun WD; Leonard TW Obstet Gynecol; 2004 Feb; 103(2):245-53. PubMed ID: 14754691 [TBL] [Abstract][Full Text] [Related]
11. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. Parish SJ; Gillespie JA Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials. Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Racketa J; Shi H; Chines AA; Mirkin S J Womens Health (Larchmt); 2014 Jan; 23(1):18-28. PubMed ID: 24206058 [TBL] [Abstract][Full Text] [Related]
13. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide. Palacios S; Currie H; Mikkola TS; Dragon E Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Simon J; Klaiber E; Wiita B; Bowen A; Yang HM Menopause; 1999; 6(2):138-46. PubMed ID: 10374221 [TBL] [Abstract][Full Text] [Related]
15. Hormone Therapy and Other Treatments for Symptoms of Menopause. Hill DA; Crider M; Hill SR Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271 [TBL] [Abstract][Full Text] [Related]
16. Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results. Erel CT; Gezer A; Sentürk LM; Somunkiran A; Kaleli S; Seyisoglu H J Reprod Med; 2007 Dec; 52(12):1079-84. PubMed ID: 18210897 [TBL] [Abstract][Full Text] [Related]
17. Ultra-low dose - new approaches in menopausal hormone therapy. Stute P; Becker HG; Bitzer J; Chatsiproios D; Luzuy F; von Wolff M; Wunder D; Birkhäuser M Climacteric; 2015 Apr; 18(2):182-6. PubMed ID: 25335192 [TBL] [Abstract][Full Text] [Related]
18. [Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?]. Valéra MC; Chantalat E; Vinel A; Benoit T; Guillaume M; Game X; Gourdy P; Trémollières F; Payrastre B; Arnal JF Presse Med; 2015; 44(7-8):805-11. PubMed ID: 26278157 [TBL] [Abstract][Full Text] [Related]
19. 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes. Gerlinger C; Gude K; Schmelter T; Schaefers M; Endrikat J Climacteric; 2015; 18(4):512-7. PubMed ID: 26000627 [TBL] [Abstract][Full Text] [Related]
20. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Kuller LH J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556 [No Abstract] [Full Text] [Related] [Next] [New Search]